Chubb Limited CB Q1 2026 Earnings Slight EPS Beat Amid Modest Stock Pullback MGTX Q1 2026 Earnings Missed EPS Estimates as PreRevenue Biotech Advances Pipeline Lyell Immunopharma LYEL Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline Novo Nordisk AS NVO Q1 2026 Earnings Strong EPS Beat Driven by Obesity and Diabetes Portfolio MU Q1 2026 Earnings Strong EPS Beat Drives 19 Stock Surge DIS Q1 2026 Earnings Beat on EPS Amid Mixed Segment Performance